# Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

> **NCT00244556** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 300 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate plus ENBREL or ENBREL alone

## Key facts

- **NCT ID:** NCT00244556
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 300 (—)
- **Last updated:** 2013-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244556, "Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00244556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*